Alberto F.
- Country
- Italy
- Department
- SC Oncologia Medica
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
- Phase 3 Randomized Study of Pembrolizumab Versus Platinum-Based Chemotherapy in Mismatch Repair Deficient Advanced or Recurrent Endometrial Carcinoma
Data & Insights
Has run more than one trial at 207 of 345 partner sites.
Specializations
Ovarian Cancer Research
Specializes in investigating treatments for advanced epithelial ovarian cancer and its variants, including fallopian tube and primary peritoneal cancers. Has particular expertise in studying both BRCA wild-type and BRCA-mutated disease variants.
- Maintenance Therapy Approaches
- PARP Inhibitor Applications
- Platinum-Sensitive Disease Management
Focuses on novel therapeutic combinations and maintenance strategies for recurrent disease.
Endometrial Cancer Studies
Conducts research in advanced and recurrent endometrial carcinoma, with emphasis on innovative treatment approaches. Investigates both early-stage and metastatic disease manifestations.
- Immunotherapy Applications
- Targeted Therapeutic Approaches
- Grade-Specific Treatments
Evaluates novel therapeutic agents and their efficacy in various disease stages.
Advanced Therapeutic Development
Explores innovative treatment modalities for gynecologic cancers, including targeted therapies and combination approaches. Specializes in evaluating novel therapeutic agents for hard-to-treat cancers.
- Biomarker-Driven Treatments
- Novel Drug Combinations
- Precision Medicine Approaches
Investigates personalized treatment strategies based on molecular and genetic profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.